化合物Lanreotide acetate T8359
面议
- TargetMol
- 生产商
- 进口
- 美国
- 现货
- 全国
- 8
- 1
Product IntroductionBioactivity英文名: Lanreotide acetate描述: Lanreotide acetate (BIM 23014 acetate) 是生长抑素类似物，具有抗肿瘤活性，可用于类癌综合
AI问答
配套的仪器设备？
可以搭配的相关耗材试剂？
耗材描述
Product Introduction
Bioactivity
英文名: Lanreotide acetate
描述: Lanreotide acetate (BIM 23014 acetate) 是生长抑素类似物，具有抗肿瘤活性，可用于类癌综合症。
动物实验: Animal Model:Male nude mice, 8 weeks old and 20–25?g in body weight (GH3 tumor-bearing nude mice).Dosage: 2.5, 5, 10?mg/kg. Administration:Subcutaneous; daily for 5 days[1]
体内活性: In a mouse GH3 tumor xenograft model, lanreotide 10 mg/kg moderately inhibited the growth of GH3 tumors, with a 4x tumor growth delay (TGD) time that ranged from 4.5 to 8.3 days. Fractionated local tumor radiation alone significantly inhibited tumor growth and produced a TGD of 35.1+/-5.7 days for 250 cGy fractions[1].
存储条件: keep away from moisturePowder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 22.5 mg/mL (19.46 mM)
关键字: Lanreotide | Lanreotide acetate | inhibit | hormone | Lanreotide Acetate | apoptosis | BIM23014 Acetate | pituitary | BIM 23014 Acetate | Inhibitor | 108736-35-2 free base | GH3 cells | BIM 23014 | 108736-35-2 | tumor | BIM23014 | BIM-23014 | BIM-23014 Acetate | adenoma | GH-secreting
相关库: Drug Repurposing Compound Library | Approved Drug Library | Cyclic Peptide Library | Anti-Cancer Drug Library | Clinical Compound Library | Bioactive Compounds Library Max | Peptide Compound Library | Anti-Cancer Clinical Compound Library | Anti-Cancer Approved Drug Library | Anti-Cancer Active Compound Library
Bioactivity
英文名: Lanreotide acetate
描述: Lanreotide acetate (BIM 23014 acetate) 是生长抑素类似物，具有抗肿瘤活性，可用于类癌综合症。
动物实验: Animal Model:Male nude mice, 8 weeks old and 20–25?g in body weight (GH3 tumor-bearing nude mice).Dosage: 2.5, 5, 10?mg/kg. Administration:Subcutaneous; daily for 5 days[1]
体内活性: In a mouse GH3 tumor xenograft model, lanreotide 10 mg/kg moderately inhibited the growth of GH3 tumors, with a 4x tumor growth delay (TGD) time that ranged from 4.5 to 8.3 days. Fractionated local tumor radiation alone significantly inhibited tumor growth and produced a TGD of 35.1+/-5.7 days for 250 cGy fractions[1].
存储条件: keep away from moisturePowder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 22.5 mg/mL (19.46 mM)
关键字: Lanreotide | Lanreotide acetate | inhibit | hormone | Lanreotide Acetate | apoptosis | BIM23014 Acetate | pituitary | BIM 23014 Acetate | Inhibitor | 108736-35-2 free base | GH3 cells | BIM 23014 | 108736-35-2 | tumor | BIM23014 | BIM-23014 | BIM-23014 Acetate | adenoma | GH-secreting
相关库: Drug Repurposing Compound Library | Approved Drug Library | Cyclic Peptide Library | Anti-Cancer Drug Library | Clinical Compound Library | Bioactive Compounds Library Max | Peptide Compound Library | Anti-Cancer Clinical Compound Library | Anti-Cancer Approved Drug Library | Anti-Cancer Active Compound Library
猜你喜欢
感兴趣产品